7.05
-0.1(-1.40%)
Currency In USD
| Previous Close | 7.15 |
| Open | 7.2 |
| Day High | 7.2 |
| Day Low | 7.05 |
| 52-Week High | 54.95 |
| 52-Week Low | 5.01 |
| Volume | 3,189 |
| Average Volume | 10,632 |
| Market Cap | 4.15M |
| PE | 0.01 |
| EPS | 958.65 |
| Moving Average 50 Days | 8.24 |
| Moving Average 200 Days | 12.7 |
| Change | -0.1 |
If you invested $1000 in Quoin Pharmaceuticals, Ltd. (QNRX) since IPO date, it would be worth $0.44 as of August 20, 2025 at a share price of $7.05. Whereas If you bought $1000 worth of Quoin Pharmaceuticals, Ltd. (QNRX) shares 5 years ago, it would be worth $4.4 as of August 20, 2025 at a share price of $7.05.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy
GlobeNewswire Inc.
Aug 18, 2025 12:30 PM GMT
ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the appointment of its
Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton
GlobeNewswire Inc.
Aug 12, 2025 12:30 PM GMT
New Episode Highlights the Painful, Often Misunderstood Reality of Living with Netherton Syndrome and the Urgent Need for Effective TreatmentsASHBURN, Va., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the
Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025
GlobeNewswire Inc.
Jul 31, 2025 12:30 PM GMT
ASHBURN, Va., July 31, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to relea